RespireRx Pharmaceuticals Inc (CE) (RSPI) Quote

New slide deck for EndeavourRx on the website, February 7, 2025. Not pretty or polished, but a clearer, updated picture of their intent, strategy, and assets. No timeline however.

https://endeavourrx.com/slide-deck

I hope so too. Continual communication and presentation is vital to any organization whether publicly traded or not. Clearly both have been lacking for a long time with this company. One would think a lightbulb would suggest to do something different.

Considering they intentionally "paused" the filing process and they have very significant progress with 2 different drug platforms heading to clinical trials, I am hoping the past 8 months has indeed developed a forward map or plan to sustain continual efforts on all fronts for years and all stakeholders can reap rewards, especially those patients who may benefit tremendously if these candidates can cross the goal line... They surely deserve that chance. GLTA.

With interactive broker app you can see level 1, I don’t have an account with them

I don't think there is any published bid x ask across all platforms.

Pretty much is just peanuts x peanuts here on the ole expert market...

With all the possible various things going on I sure hope they have someone experienced in a PR campaign and know how to get the most out of the news we could have coming!!!

The Canadians have the advantage on buying because when the news from the company when they start or started filing, will move SP. When we get off EM and the news on investors,BP JV this could skip nickels and dimes and the advancement into clinical levels lookout !! JMHO GLTA that stuck it out !!

Someone has level 1 please?

Interesting to know is that I am aware of another Expert Market stock that shareholders are paying the fees to be updated to the OTC and report that all paperwork and fees being paid should reinstate trading within 2-3 weeks. I am hopeful that RSPI is well underway in doing the same. If so, we could see some fireworks very soon following the press release.

Maybe preparing for some liquidity to enter here, even on this expert market?

I still am confused as to what constitutes an expert. If you are an accreddited/sophisticated investor can you just call up your broker or any broker to acquire a position of shares? Whereas it is a no go for the average retail investor?

If the company indicates that they are making the moves to get the filings completed and off the EM soon, it stands to reason that with multiple clinical trials likely looming and possible partnerships in the background that there would be heightened investor interest. Especially at these dirt cheap prices below a penny... With another conference next week upcoming, institutional investors (who I think are experts) could be looking to take up positions as well.

Yeap as Jimmy Buffet sang Cmon Monday GLTA

LT, I am making the same observations. Also, my experience in watching trading that MM's do position prior to positive activity. Perhaps some sort of filing or update is in process and has been observed. Not sure how they know but always interesting.

Have a great weekend. Hopefully we receive the update early next week.

What's up with all these odd lot trades/transactions lately?

See many approximately $20, $40, $80 trades... besides the very strange trades at less than $1...

Is this market maker/broker positioning? Settling/Covering etc... I have noticed on other otc stocks in the distant past similar preceeding higher interest time periods... Maybe the train whistle went off? Been waiting for the train to leave the station.. lol

Everything is coming , we will hopefully have the answers to our concerns. Catch up on **Monday** with you all. GLTA

I would hope so...

I don't think you can approach institutional investors or BP for potential funding and deals without discussing all your stakeholders which includes retail.

And really there likely is some small convertible debt remaining, warrants issued to BOD member and CEO for funds and the series J preferred shares which all are dependent on the shareprice and the stock actually trading with liquidity.

Hopefully, RSPI updates their filing before the July change. I suspect we will know the status of moving off the Expert Market when Jeff releases the promised news. Expecting it at any time now.

https://blog.otcmarkets.com/2024/10/14/the-evolution-of-the-otc-market-introducing-otcid/

CDT, An AI drug development company is a good example of what can happen in the world of developing medical treatment. They are going crazy this AM.
Come on Jeff, get this off the Expert Market.

We at 0022 let's see if we break over 0025

Nah that's a reach was supposed to come out during the new year been delayed for over a month smh

Maybe they want to be back onto the OTC before providing updates?

Try giving Questrade a shout. EOM

Day 2 let's see if newes letter drops at 8 lol

Ok. I called RBC. It's a no go for me

It could get really interesting.

There are very few shares floating around on this EM market, which should be expected especially trading for peanuts. Probably when this trades for a penny or two or three or more there will be a lot more liquidity as some investors reduce positions and others accumulate for the journey into clinical trials and the potential to unlock blockbuster drug development efforts which bring potentially blockbuster ROI which could realistically be .50 or more longer term....

There certainly was a purpose for them to go this EM route, and just now hitting the institutional investor conferences. I don't think you go to this higher level of investor community with nothing to present but stale activity for almost a year.  As speculated and would be logical that some level of negotiations were ongoing in the background. Their past filings indicate efforts to set up ALL their assets for license, partnering or sale.... Those efforts all require negotiation and dealmaking!

Yeah, no reason to be in a hurry with long term shares...

Obviously we are starved for information and updates, which hopefully are coming soon. This will all help to reasonably project what is possible and or likely to occur in the coming 3-6 months and next few years.

Everyone has an opinion on value and different investment goals, all I know is there is a massive gap between current valuation of 1-2 million, essentially peanuts... versus plausible valuation/speculative value which considering the pharma industry, comparable asset progression in other companies and all the ingredients here, could easily be 100 million range entering multiple clinical efforts. Somewhere in the middle should be a sustainable goal for all companies. (i.e not severely undervalued which limits building anything and not way overvalued which is problematic in other ways.) Longer term clinical success will dictate whether any of these assets become breakthrough level and command levels of ROI and value we can currently only dream about.

I would agree with that. Eagerly waiting the news.

That would be great if still on the EM, once off the EM sell price will be much higher. GLTA

I hope you wake up someday and it is all gone!

I put up 1.640m everyday at .05 for laughs if it hits great , if not no biggie will just hold for longer. Waiting on a reply to see how things went and if all is on track for the release of S/L . GLTA

From my understanding no brokerage in the United States are permitted to allow buying of any expert market stock.
I've been told Canadian Brokerages do allow for the purchase of expert market stocks.

No! It is listed on the Expert Marker. Waiting for records to be updated and approval for the US market. You may be able to buy through a Canadian broker. Very few are being placed as a sell order and only the lucky get shares. Best bet with those working with Canadian brokers is placing a high bid of .0025 or higher. Looking for a penny or more when it goes back on the OTC. Good luck!

Royal Bank of Canada Investing allows be to buy it. I might have had to qualify, which I did so I ran into no restrictions nor having to get approval for every transactions. This may not apply to any random person opening an RBCI account.

Is this ticker purchase able thru some of the major brokerages....Even to buy a million shares would cause the price to really pop?

Hopefully things are in motion to get off the EM sooner than later and then they roll into continued updates, clinical progress, license/JV/partner, etc. basically act like most clinical stage pharma…

I absolutely hate these price fluctuations on the expert market! Nothing is for Real! I Can't wait to get listed again!

Someone is trying to get Cheapies again. But I suspect there is no longer much to get anymore. I put up a token amount at 0.0035, for a laugh.

We 6 on BOB! Eyes are gearing towards us

Let's see if newes letter drops at 8 lol

Who knows but the volume is still very very small. If you are retail, I think you have to find an account in Canada, otherwise it is likely brokers or certain "sophisticated" investors scooping up scraps or settling out positions.

Hopefully we will get more detail in some update or PR, but the reality is simple. The amapkine platform is heading into a key clinical trial and the gabakine candidate has a superior preclinical profile heading towards human trials. Timing of such trials is an unknown. As the company works to collect institutional investment, lock in partnerships or deals (all of which they have been stating for years and prepping their assets for)... AND as they logically are hopefully making moves to get off the EM, I think investors are catching on and looking for options to be a part of these assets heading into clinicals.

Even if they had to double the OS shares to account for all conversions, warrants, debt, etc. That would only be a 4 million market cap today! Peanuts. Pharma's with this level of assets can easily trade 10-50x this level while clinicals are ongoing and with any clinical success unlocking significantly more value. But my position is long, so maybe a different perspective than many speculative investors.

Will do , maybe that was some of the issues they are addressing, maybe it was issues with grants and funding , who knows at this point. Dont want to guess hopefully it all comes together in the S/L GLTA

"Yes, SEC-registered companies (public companies) are required to have a majority of independent (outside) directors on their boards."
Not so. That's an exchange requirement (NYSE, AMEX, NASDAQ), not a public/SEC registered company requirement. RSPI is an SEC registered public company and it hasn't had a majority of independent Directors in some time, if ever.

Obviously it isn't just the website that needs updating. The answer to my question should have been in the latest 10-K had they filed it.
Maybe if Jeff tells you more about the board meeting after it occurs you could ask him who is on the Board. Or, in case he's reading this board, maybe he can just tell you.

Yes strange that others have been named , but not on website but as others have stated an updated webpage is needed. I think they are adding outside members for SEC rules
Yes, SEC-registered companies (public companies) are required to have a majority of independent (outside) directors on their boards. This is a key aspect of corporate governance and is mandated by stock exchange rules like those of the New York Stock Exchange and Nasdaq.
Further Clarification:
Independent Directors:
These are board members who are not employees, officers, or otherwise materially affiliated with the company. They are meant to provide an unbiased perspective and protect the interests of shareholders.
SEC Requirements:
While not explicitly stated in the SEC's regulations, the stock exchange listing requirements, which SEC-registered companies must adhere to, mandate a majority of independent directors.
Importance of Independence:
Independent directors are crucial for maintaining good corporate governance, preventing conflicts of interest, and ensuring that the board can make objective decisions in the best interests of the company and its shareholders.
Examples:
Both the New York Stock Exchange and Nasdaq require a majority of independent directors on their listed companies' boards.
Key Committees:
Independent directors are also often required to make up the majority of crucial board committees, such as the audit committee and compensation committee.
In essence, while a company can have inside directors (employees or executives), the majority of the board must be comprised of outside, independent individuals to ensure a strong corporate governance structure.

Thanks. I had seen that and it's one of the reasons I asked. It differs from other sources:

Board of Directors
Arnold S. Lippa Chairman, CSO, Interim CEO
Kathryn MacFarlane
Jeff E. Margolis
https://www.otcmarkets.com/stock/RSPI/profile

"As discussed in more detail below, on January 18, 2024, the Board of Directors (the “Board”) of RespireRx Pharmaceuticals Inc. (the “Company”) appointed a new director, Dariusz Nasiek to the Board who is considered to be an outside director."
https://www.sec.gov/ix?doc=/Archives/edgar/data/849636/000149315224003131/form8-k.htm

"Joseph Siegelbaum 75 2023 Director of the Company and retired partner of the law firm, Goodwin Procter LLP"
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000849636/000149315223012542/form10-k.htm

I got the same email a month ago when I said as we sit in EM are progress in research or clinical achievement still advancing

https://respirerx.com/board-of-directors/ here is what is on the site showing BOD ,

I am just glad he is able and willing to tell us what he can when he is asked. I might have to send him a gift card for plucking his nerves . It was a great answer so we can put that topic on the shelf. a crazy day here , strange volume for the EM hahahha

Appreciate your honorary investor relations efforts! lol

Over a million share bought while on expert market
Impressive

Is this Canada buying?

No. Development has not stopped. More in the shareholder letter. the reply